• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

NIHR Oxford Health Biomedical Research Centre

MENUMENU
  • About
    • About
    • Management and core team
    • Our partners
    • Timeline of our key achievements
    • Core facilities
    • Work with us
    • Contact
  • Departments
    • NIHR Oxford Cognitive Health Clinical Research Facility
    • Brain Health Centre
    • Oxford Precision Psychiatry Lab (OxPPL)
    • Oxford Dementia and Ageing Research (OxDARE)
    • Treatment Resistant Depression Clinic
    • Experimental Medicine and Industry Partnership (EMIP)
  • Research Themes
    • Better Sleep
    • Brain Technologies
    • Data Science
    • Dementia
    • Depression Therapeutics
    • Flourishing & Wellbeing
    • Mental Health in Development
    • Molecular Targets
    • Pain
    • Preventing Multiple Morbidities
    • Psychological Treatments
  • COVID-19 Research
    • Overview
    • News
    • COVID-19 & clinical management of mental health issues
  • News & Events
    • News
    • Training and Events
    • Psychiatry Department Seminars
  • Patients & Public
    • About Patient and Public Involvement
    • Shape our research
    • Take part in our research
    • Resources for researchers
    • Resources for the public
    • Patient and Public Involvement Strategy
    • Young people’s involvement
  • Training Hub
You are here: Home / News / COVID-19 research / COVID-19 and psychiatric diagnosis / COVID-19 survivors at risk of neurological and psychiatric disorders

COVID-19 survivors at risk of neurological and psychiatric disorders

7th April 2021

A new study shows 1 in 3 survivors of COVID-19 received a neurological or psychiatric diagnosis within 6 months. The risk was greater in people who had severe COVID-19, but 1 in 9 patients not requiring hospitalization, also received a diagnosis.

In the study, funded by the NIHR Oxford Health BRC, researchers looked at health records of over 236,000 patients using the TriNetX electronic health records network to reveal the scale of complications affecting the brain and nervous system after COVID-19. The study is published in the Lancet Psychiatry.

Paul Harrison, Oxford Health BRC Theme Lead and Professor of Psychiatry, University Oxford, who led the study commented:

These are real-world data from a large number of patients. They confirm worries that serious disorders affecting the nervous system can occur after COVID-19. Though the risks are greater in the people who were most ill with the infection, they are also present in those who did not need hospital care. We now need to see what happens beyond six months. The study cannot reveal the mechanisms involved, but does point to the need for urgent research to identify these, with a view to preventing or treating them.”

For 1 in 8 people it was their first neurological or psychiatric diagnosis. Most individual diagnoses were more common after COVID-19 than after influenza or other respiratory infections, and included stroke, dementia, psychosis and neuromuscular disorders, as well as psychiatric disorders like anxiety. The risks were greater in people who had needed hospitalization or intensive care. In the latter group, almost half received a diagnosis within six months, including nearly 1 in 10 with a stroke and 1 in 20 with dementia.

Dr Max Taquet, NIHR Academic Clinical Fellow, who conducted the analyses, said:

The results show that brain diseases and psychiatric disorders are quite common after COVID-19, and more so than after other respiratory infections, even when patients are matched for other risk factors. We now need to see what happens beyond six months. The study cannot reveal the mechanisms involved, but does point to the need for urgent research to identify these, with a view to preventing or treating them. Clinical services in primary care, neurology and psychiatry need to be ready to cope with an increased demand that will likely continue for some time after the pandemic is under control.“

Read the full paper here.

Filed Under: COVID-19 and psychiatric diagnosis, COVID-19 research, News

Primary Sidebar

News Categories

  • News
    • Clinical Research Facility
    • COVID-19 research
      • Children, young people and family mental health
      • COVID-19 and psychiatric diagnosis
      • Online therapies and resources for clinicians
      • Patient and Public Involvement in the pandemic
      • PHOSP COVID
      • Vaccination and vaccine hesitancy
    • Research Themes
      • Better Sleep
      • Brain Technologies
      • Data Science
      • Dementia
      • Depression Therapeutics
      • Flourishing & Wellbeing
      • Mental Health in Development
      • Molecular Targets
      • Pain
      • Preventing Multiple Morbidities
      • Psychological Treatments
    • Training and Development
Tweets by OxHealthBRC
Follow @OxHealthBRC

Footer

Follow us

  • LinkedIn
  • Twitter
  • YouTube

Improving brain health: the future in mind

The National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) is a partnership between Oxford Health NHS Foundation Trust and the University of Oxford.  We are part of the Oxford Academic Health Partners.
Oxford Academic Health Partners
  • Sitemap
  • Accessibility
  • Disclaimer
  • Cookies
  • Contact

© 2023 NIHR Oxford Health Biomedical Research Centre · Log in

Cookies

This site uses cookies: See our privacy policy